The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Zorina V.V.

Research Institute of Internal and Preventive Medicine — Branch of the Institute of Cytology and Genetics Siberian Branch of Russian Academy of Sciences

Garbuzova E.V.

Research Institute of Internal and Preventive Medicine — Branch of the Institute of Cytology and Genetics Siberian Branch of Russian Academy of Sciences

Afanaseva A.D.

Research Institute of Internal and Preventive Medicine — branch of the Institute of Cytology and Genetics Siberian Branch of Russian Academy of Sciences

Shakhtshneider E.V.

Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences;
Institution of Internal and Preventive Medicine — Branch of the Federal Research Center Institute of Cytology and Genetics Siberian Branch of the Russian Academy of Sciences

Logvinenko I.I.

Institution of Internal and Preventive Medicine — Branch of the Federal Research Center Institute of Cytology and Genetics Siberian Branch of the Russian Academy of Sciences

The post-COVID syndrome phenotypes and cardiometabolic risk factors

Authors:

Zorina V.V., Garbuzova E.V., Afanaseva A.D., Shakhtshneider E.V., Logvinenko I.I.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2024;27(9): 44‑51

Read: 1075 times


To cite this article:

Zorina VV, Garbuzova EV, Afanaseva AD, Shakhtshneider EV, Logvinenko II. The post-COVID syndrome phenotypes and cardiometabolic risk factors. Russian Journal of Preventive Medicine. 2024;27(9):44‑51. (In Russ.)
https://doi.org/10.17116/profmed20242709144

Recommended articles:
Diagnostic stra­tegies for post-COVID syndrome. Russian Journal of Preventive Medi­cine. 2025;(6):126-130
The role of drug Cyto­flavin in the correction of dysautonomia in patients with post-COVID syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):140-146
Reha­bilitation of patients with post-COVID syndrome depe­nding on C(159)T poly­morphism of SD-14 gene. Problems of Balneology, Physiotherapy and Exercise Therapy. 2025;(1):42-50
Modern approaches to diagnosis and treatment of postinfectious asthenic syndrome in children. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):42-52
Sleep diso­rders after COVID-19 in patients with primary headaches. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):127-132

References:

  1. WHO Coronavirus Disease (COVID-19) Dashboard [Internet]. Accessed April 15, 2024. https://covid19.who.int
  2. Fernández-de-las-Peñas C, Palacios-Ceña D, Gómez-Mayordomo V, et al. Prevalence of Post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis. European Journal of Internal Medicine. 2021;2021:55-70.  https://doi.org/10.1016/j.ejim.2021.06.009
  3. Chen C, Haupert SR, Zimmermann L, et al. Global prevalence of post COVID-19 condition or long COVID: A meta-analysis and systematic review. The Journal of Infectious Diseases. 2022;16:jiac136. https://doi.org/10.1093/infdis/jiac136
  4. Ceban F, Ling S, Lui LMW, et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain, Behavior, and Immunity. 2022;101:93-135.  https://doi.org/10.1016/j.bbi.2021.12.020
  5. Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infectious Diseases (London, England). 2021;53(10):737-754. 
  6. COVID-19 rapid guideline: managing the long-term effects of COVID-19 NICE guideline. Accessed April 15, 2024. https://www.nice.org.uk/guidance/ng188
  7. Vsemirnaya organizaciya zdravooxraneniya (VOZ). Koronavirusnaya infekciya (COVID-19): postkovidny`j sindrom — 28 marta 2023 g. Accessed April 15, 2024. (In Russ.). https://www.who.int/ru/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-post-covid-19-condition
  8. Dedov II, Mokrysheva NG, Mel’nichenko GA, et al. Obesity. Clinical guidelines. Consilium Medicum. 2021;23(4):311-325. (In Russ.).
  9. Diagnostics and correction of lipid metabolism disorders in order to prevent and treat of atherosclerosis Russian recommendations VII revision. Ateroskleroz i dislipidemii. 2020;1(38):7-42. (In Russ.).
  10. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International Supplements. 2013;3:1-150. 
  11. Thompson EJ, Williams DM, Walker AJ, et al. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nature Communications. 2022;13:3528. https://doi.org/10.1038/s41467-022-30836-0
  12. Emecen AN, Keskin S,Turunc O, et al. The presence of symptoms within 6 months after COVID-19: a single-center longitudinal study. Irish Journal of Medical Science. 2023;192(2):741-750.  https://doi.org/10.1007/s11845-022-03072-0
  13. Sykes DL, Holdsworth L, Jawad N, et al. Post-COVID-19 Symptom Burden: What is Long-COVID and How Should We Manage It? Lung. 2021; 199(2):113-119.  https://doi.org/10.1007/s00408-021-00423-z
  14. D’Cruz RF, Waller MD, Perrin F, et al. Chest radiography is a poor predictor of respiratory symptoms and functional impairment in survivors of severe COVID-19 pneumonia. ERJ Open Research. 2021;7(1):00655-2020. https://doi.org/10.1183/23120541.00655-2020
  15. Bai F, Tomasoni D, Falcinella C, et al. Female gender is associated with long COVID syndrome: a prospective cohort study. Clinical Microbiology and Infection. 2022;28(4):611.e9-611.e16.  https://doi.org/10.1016/j.cmi.2021.11.002
  16. Xiong Q, XuM, Li J, et al. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clinical Microbiology and Infection. 2021;27:89-95.  https://doi.org/10.1016/j.cmi.2020.09.023
  17. Markova TN, Anchutina AA, Garib VYu, et al. The prevalence of carbohydrate metabolism disorders in patients after coronavirus infection. Zdorov’e megapolisa. 2022;3(4):32-41. (In Russ.).
  18. Арутюнов Г.П., Тарловская Е.И., Арутюнов А.Г. и др. Клинические особенности постковидного периода. Результаты международного регистра «Анализ динамики коморбидных заболеваний у пациентов, перенесших инфицирование SARS-CoV-2 (АКТИВ SARS-CoV-2)». Предварительные данные (6 месяцев наблюдения). Российский кардиологический журнал. 2021;26(10):4708.
  19. Arutyunov GP, Tarlovskaya EI, Arutyunov AG, et al. Clinical features of post-COVID-19 period. Results of the international register «Dynamic analysis of comorbidities in SARS-CoV-2 survivors (AKTIV SARS-CoV-2)». Data from 6-month follow-up. Rossijskij kardiologicheskij zhurnal. 2021;26(10):4708. (In Russ.). https://doi.org/10.15829/1560-4071-2021-4708
  20. Gentilotti E, Górska A, Tami A, et al. Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort. EClinicalMedicine. 2023;62:102107. https://doi.org/10.1016/j.eclinm.2023.102107
  21. Ståhlberg M, Reistam U, Fedorowski A, et al. Post-COVID-19 Tachycardia Syndrome: A Distinct Phenotype of Post-Acute COVID-19 Syndrome. The American Journal of Medicine. 2021;134(12):1451-1456. https://doi.org/10.1016/j.amjmed.2021.07.004
  22. Lier J, Stoll K, Obrig H, et al. Neuropsychiatric phenotype of post COVID-19 syndrome in non-hospitalized patients. Frontiers in Neurology. 2022;13:88359. https://doi.org/10.3389/fneur.2022.988359
  23. Diem L, Schwarzwald A, Friedli C, et al. Multidimensional phenotyping of the post-COVID-19 syndrome: A Swiss survey study. CNS Neuroscience and Therapeutics. 2022;28(12):1953-1963. https://doi.org/10.1111/cns.13938
  24. Daines L, Zheng B, Pfeffer P, et al. A clinical review of long-COVID with a focus on the respiratory system. Current Opinion in Pulmonary Medicine. 2022;28(3):174-179.  https://doi.org/10.1097/MCP.0000000000000863
  25. Montani D, Savale L, Noel N, et al. Post-acute COVID-19 syndrome. European Respiratory Review. 2022;31(163):210185. https://doi.org/10.1183/16000617.0185-2021
  26. Sharquie KE, Jabbar RI. COVID-19 infection is a major cause of acute telogen effluvium. Irish Journal of Medical Science. 2022;191(4):1677-1681. https://doi.org/10.1007/s11845-021-02754-5
  27. Mieczkowska K, Deutsch A, Borok J. Telogen effluvium: a sequela of COVID-19. International Journal of Dermatology. 2021;60(1):122-124.  https://doi.org/10.1111/ijd.15313
  28. Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. The New England Journal of Medicine. 2020;382:1708-1720. https://doi.org/10.1056/NEJMoa2002032
  29. Zhang JJ, Cao YY, Tan G, et al. Clinical, radiological, and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID-19 patients. Allergy. 2021;76:533-550. 

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.